See more : Guangxi Yuegui Guangye Holdings Co., Ltd. (000833.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of International Flavors & Fragrances Inc. (IFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of International Flavors & Fragrances Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- YOC AG (YOC.DE) Income Statement Analysis – Financial Results
- Oceaneering International, Inc. (OII) Income Statement Analysis – Financial Results
- China VTV Ltd. (CVTV) Income Statement Analysis – Financial Results
- SYNLAB AG (SYAB.DE) Income Statement Analysis – Financial Results
- Papyless Co., Ltd. (3641.T) Income Statement Analysis – Financial Results
International Flavors & Fragrances Inc. (IFF)
About International Flavors & Fragrances Inc.
International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 11.48B | 12.44B | 11.66B | 5.08B | 5.14B | 3.98B | 3.40B | 3.12B | 3.02B | 3.09B | 2.95B | 2.82B | 2.79B | 2.62B | 2.33B | 2.39B | 2.28B | 2.10B | 1.99B | 2.03B | 1.90B | 1.81B | 1.84B | 1.46B | 1.44B | 1.41B | 1.43B | 1.44B | 1.44B | 1.32B | 1.19B | 1.13B | 1.02B | 962.80M | 869.50M | 839.50M | 745.90M | 620.70M | 501.00M |
| Cost of Revenue | 7.80B | 8.29B | 7.92B | 3.00B | 3.03B | 2.29B | 1.92B | 1.72B | 1.67B | 1.73B | 1.67B | 1.65B | 1.68B | 1.53B | 1.39B | 1.42B | 1.32B | 1.21B | 1.17B | 1.16B | 1.09B | 1.04B | 1.06B | 762.31M | 735.40M | 714.50M | 722.90M | 731.00M | 706.30M | 641.40M | 578.70M | 548.00M | 498.50M | 474.60M | 433.00M | 414.10M | 372.60M | 311.00M | 245.90M |
| Gross Profit | 3.68B | 4.15B | 3.74B | 2.09B | 2.11B | 1.68B | 1.48B | 1.40B | 1.35B | 1.36B | 1.28B | 1.18B | 1.10B | 1.09B | 935.13M | 970.63M | 952.21M | 884.13M | 824.40M | 873.42M | 809.06M | 773.41M | 780.33M | 700.49M | 704.10M | 692.80M | 703.90M | 705.10M | 733.20M | 673.80M | 609.90M | 578.40M | 518.50M | 488.20M | 436.50M | 425.40M | 373.30M | 309.70M | 255.10M |
| Gross Profit Ratio | 32.07% | 33.37% | 32.04% | 41.03% | 41.10% | 42.31% | 43.52% | 44.89% | 44.71% | 44.10% | 43.49% | 41.66% | 39.62% | 41.66% | 40.20% | 40.62% | 41.83% | 42.19% | 41.36% | 42.95% | 42.55% | 42.75% | 42.32% | 47.89% | 48.91% | 49.23% | 49.33% | 49.10% | 50.93% | 51.23% | 51.31% | 51.35% | 50.98% | 50.71% | 50.20% | 50.67% | 50.05% | 49.90% | 50.92% |
| Research & Development | 636.00M | 603.00M | 629.00M | 356.86M | 346.13M | 311.58M | 286.03M | 254.26M | 246.10M | 253.64M | 259.84M | 233.71M | 219.78M | 218.77M | 193.84M | 212.70M | 199.02M | 185.69M | 179.81M | 175.17M | 159.29M | 144.03M | 135.25M | 112.67M | 103.80M | 98.40M | 94.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 707.46M | 557.31M | 566.22M | 509.56M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.79B | 1.77B | 1.75B | 948.83M | 876.12M | 707.46M | 557.31M | 566.22M | 520.09M | 514.89M | 505.88M | 453.54M | 443.97M | 447.39M | 376.54M | 381.84M | 375.29M | 351.92M | 339.32M | 341.31M | 308.95M | 305.16M | 313.34M | 258.65M | 262.60M | 238.70M | 227.10M | 317.00M | 308.50M | 288.80M | 268.90M | 280.80M | 234.80M | 220.70M | 198.10M | 191.80M | 173.70M | 151.40M | 125.70M |
| Other Expenses | 0.00 | 727.00M | 732.00M | 192.61M | 193.10M | 35.24M | 20.97M | 9.35M | -3.18M | 2.81M | 15.64M | -1.45M | 0.00 | 0.00 | 6.15M | 6.15M | 12.88M | 14.84M | 15.07M | 14.83M | 12.63M | 12.63M | 46.09M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| Operating Expenses | 5.79B | 3.10B | 3.11B | 1.50B | 1.42B | 1.09B | 878.03M | 844.25M | 766.19M | 768.53M | 765.72M | 687.25M | 663.76M | 666.16M | 576.54M | 600.69M | 587.19M | 552.46M | 534.21M | 531.31M | 480.87M | 461.82M | 494.67M | 440.67M | 422.80M | 386.10M | 371.80M | 364.80M | 349.20M | 325.20M | 304.00M | 314.80M | 264.20M | 248.90M | 222.40M | 214.50M | 194.40M | 169.80M | 140.30M |
| Cost & Expenses | 13.62B | 11.39B | 11.03B | 4.50B | 4.44B | 3.39B | 2.80B | 2.56B | 2.44B | 2.49B | 2.43B | 2.33B | 2.35B | 2.20B | 1.97B | 2.02B | 1.91B | 1.76B | 1.70B | 1.69B | 1.57B | 1.50B | 1.56B | 1.20B | 1.16B | 1.10B | 1.09B | 1.10B | 1.06B | 966.60M | 882.70M | 862.80M | 762.70M | 723.50M | 655.40M | 628.60M | 567.00M | 480.80M | 386.20M |
| Interest Income | 0.00 | 336.00M | 289.00M | 132.00M | 138.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 380.00M | 336.00M | 289.00M | 131.80M | 138.22M | 132.56M | 65.36M | 52.99M | 46.06M | 46.07M | 46.77M | 41.75M | 44.64M | 48.71M | 61.82M | 74.01M | 41.54M | 25.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.14B | 1.18B | 1.16B | 325.36M | 323.33M | 173.79M | 117.97M | 102.47M | 89.60M | 89.35M | 83.23M | 76.67M | 75.33M | 79.24M | 78.53M | 75.99M | 82.79M | 89.73M | 91.93M | 91.00M | 86.72M | 84.46M | 123.49M | 69.34M | 56.40M | 49.00M | 50.30M | 47.80M | 40.70M | 36.40M | 35.10M | 34.00M | 29.40M | 28.20M | 24.30M | 22.70M | 20.70M | 18.40M | 14.60M |
| EBITDA | -996.00M | -110.00M | 1.80B | 897.68M | 1.02B | 753.60M | 719.59M | 678.58M | 674.76M | 684.21M | 615.00M | 561.84M | 493.51M | 487.54M | 412.89M | 430.52M | 442.62M | 428.56M | 402.17M | 470.21M | 414.92M | 396.06M | 409.15M | 329.16M | 337.70M | 355.75M | 382.40M | 388.10M | 424.70M | 385.00M | 341.00M | 297.60M | 283.70M | 267.50M | 238.40M | 233.60M | 199.60M | 158.30M | 129.40M |
| EBITDA Ratio | -8.68% | 18.24% | 15.78% | 18.09% | 20.45% | 20.03% | 21.77% | 21.39% | 22.22% | 22.20% | 20.91% | 19.97% | 18.52% | 19.28% | 18.79% | 18.78% | 19.44% | 19.77% | 20.18% | 23.12% | 24.34% | 22.34% | 23.68% | 25.96% | 25.72% | 24.82% | 26.07% | 29.69% | 28.61% | 27.36% | 25.74% | 23.73% | 25.46% | 24.17% | 25.52% | 27.05% | 25.93% | 25.00% | 24.93% |
| Operating Income | -2.11B | 1.09B | 585.00M | 566.48M | 665.27M | 583.88M | 581.44M | 567.36M | 577.82M | 592.32M | 518.49M | 488.29M | 440.90M | 416.36M | 358.59M | 351.73M | 365.03M | 328.99M | 266.88M | 310.28M | 285.77M | 311.60M | 285.66M | 259.82M | 281.30M | 306.70M | 332.10M | 340.30M | 384.00M | 348.60M | 305.90M | 263.60M | 254.30M | 239.30M | 214.10M | 210.90M | 178.90M | 139.90M | 114.80M |
| Operating Income Ratio | -18.38% | 8.76% | 5.02% | 11.14% | 12.94% | 14.68% | 17.11% | 18.21% | 19.11% | 19.18% | 17.56% | 17.31% | 15.81% | 15.87% | 15.42% | 14.72% | 16.03% | 15.70% | 13.39% | 15.26% | 15.03% | 17.22% | 15.49% | 17.76% | 19.54% | 21.79% | 23.28% | 23.70% | 26.68% | 26.51% | 25.74% | 23.40% | 25.00% | 24.85% | 24.62% | 25.12% | 23.98% | 22.54% | 22.91% |
| Total Other Income/Expenses | -408.00M | -299.00M | -231.00M | -125.11M | -157.55M | -136.13M | -100.26M | -43.64M | -49.25M | -43.26M | -55.06M | -44.87M | -67.36M | -67.06M | -63.74M | -91.42M | -36.34M | -15.39M | -44.01M | -61.11M | -33.91M | -45.18M | -97.88M | -75.69M | -37.80M | 4.40M | 8.10M | -41.20M | 9.70M | 11.70M | 17.90M | 17.90M | 15.20M | 12.80M | 9.00M | -1.60M | -3.50M | -600.00K | -2.20M |
| Income Before Tax | -2.52B | -1.63B | 354.00M | 441.37M | 557.45M | 447.76M | 537.05M | 523.72M | 528.57M | 549.06M | 485.21M | 443.42M | 373.55M | 359.59M | 276.55M | 280.52M | 328.68M | 313.28M | 246.19M | 281.00M | 251.86M | 266.42M | 187.78M | 184.13M | 243.50M | 311.10M | 340.20M | 299.10M | 393.70M | 360.30M | 323.80M | 281.50M | 269.50M | 252.10M | 223.10M | 209.30M | 175.40M | 139.30M | 112.60M |
| Income Before Tax Ratio | -21.94% | -13.06% | 3.04% | 8.68% | 10.85% | 11.26% | 15.80% | 16.81% | 17.48% | 17.78% | 16.43% | 15.72% | 13.40% | 13.71% | 11.89% | 11.74% | 14.44% | 14.95% | 12.35% | 13.82% | 13.25% | 14.73% | 10.18% | 12.59% | 16.92% | 22.11% | 23.84% | 20.83% | 27.35% | 27.40% | 27.24% | 24.99% | 26.50% | 26.18% | 25.66% | 24.93% | 23.52% | 22.44% | 22.48% |
| Income Tax Expense | 45.00M | 211.00M | 75.00M | 74.00M | 97.18M | 107.98M | 241.38M | 118.69M | 116.91M | 134.52M | 131.67M | 189.28M | 106.68M | 96.04M | 81.02M | 50.89M | 81.56M | 86.78M | 53.12M | 84.93M | 79.26M | 90.47M | 71.78M | 61.12M | 81.50M | 107.30M | 122.00M | 109.20M | 144.90M | 134.30M | 121.30M | 104.80M | 100.80M | 95.40M | 84.50M | 80.60M | 68.40M | 53.60M | 42.90M |
| Net Income | -2.57B | -1.84B | 268.00M | 365.00M | 455.87M | 337.30M | 295.67M | 405.03M | 411.67M | 414.54M | 353.54M | 254.13M | 266.87M | 263.56M | 195.53M | 229.63M | 247.13M | 226.50M | 193.07M | 196.07M | 172.60M | 175.94M | 116.00M | 123.01M | 162.00M | 203.80M | 218.20M | 189.90M | 248.80M | 226.00M | 202.50M | 170.60M | 168.70M | 156.70M | 138.60M | 128.70M | 107.00M | 85.70M | 69.70M |
| Net Income Ratio | -22.35% | -14.76% | 2.30% | 7.18% | 8.87% | 8.48% | 8.70% | 13.00% | 13.62% | 13.42% | 11.97% | 9.01% | 9.57% | 10.05% | 8.41% | 9.61% | 10.85% | 10.81% | 9.69% | 9.64% | 9.08% | 9.72% | 6.29% | 8.41% | 11.25% | 14.48% | 15.29% | 13.22% | 17.28% | 17.18% | 17.04% | 15.15% | 16.59% | 16.28% | 15.94% | 15.33% | 14.35% | 13.81% | 13.91% |
| EPS | -10.06 | -7.20 | 1.10 | 3.25 | 4.04 | 3.85 | 3.73 | 5.07 | 5.19 | 5.09 | 4.32 | 3.11 | 3.30 | 3.29 | 2.48 | 2.89 | 2.86 | 2.50 | 2.06 | 2.08 | 1.84 | 1.86 | 1.21 | 1.22 | 1.53 | 1.90 | 2.00 | 1.71 | 2.24 | 2.03 | 1.78 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| EPS Diluted | -10.06 | -7.20 | 1.10 | 3.20 | 4.00 | 3.83 | 3.72 | 5.05 | 5.16 | 5.06 | 4.29 | 3.09 | 3.26 | 3.26 | 2.46 | 2.86 | 2.82 | 2.48 | 2.04 | 2.05 | 1.83 | 1.84 | 1.20 | 1.22 | 1.53 | 1.90 | 1.99 | 1.70 | 2.24 | 2.03 | 1.77 | 1.48 | 1.47 | 1.37 | 1.22 | 1.13 | 0.94 | 0.76 | 0.63 |
| Weighted Avg Shares Out | 255.00M | 255.00M | 243.00M | 112.16M | 111.97M | 87.55M | 79.07M | 79.65M | 80.45M | 80.94M | 81.32M | 81.11M | 80.46M | 79.50M | 78.40M | 79.03M | 86.54M | 90.60M | 93.72M | 94.26M | 93.80M | 94.59M | 95.87M | 100.82M | 105.88M | 107.26M | 109.10M | 111.05M | 111.07M | 111.33M | 113.76M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
| Weighted Avg Shares Out (Dil) | 255.00M | 255.00M | 243.00M | 113.63M | 113.31M | 88.12M | 79.37M | 79.98M | 80.89M | 81.49M | 81.93M | 81.83M | 81.47M | 80.44M | 79.09M | 79.72M | 87.63M | 91.33M | 94.64M | 95.64M | 94.32M | 95.62M | 96.67M | 100.82M | 105.88M | 107.26M | 109.65M | 111.71M | 111.17M | 111.46M | 114.41M | 115.27M | 114.76M | 114.38M | 113.61M | 113.89M | 113.83M | 112.76M | 110.63M |
IFF Names Ana Paula Mendonça President, Scent
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced Ana Paula Mendonça—who has dedicated her career to the advancement and commercialization of fragrance—has been named President of Scent, IFF, effective April 1. Simon Herriott, current president of Health & Biosciences and Scent...
International Flavors (IFF) Inks Deal to Sell Pharma Solutions
International Flavors (IFF) agrees to sell its Pharma Solutions business, thus marking another step in its portfolio optimization strategy.
International Flavors & Fragrances to sell pharma unit in $2.85 bln deal
International Flavors & Fragrances said on Tuesday it would sell its pharma solutions business to French plant-based ingredients maker Roquette in a deal valued at $2.85 billion, as it looks to focus on higher-margin businesses.
IFF Announces Sale of its Pharma Solutions Business to Roquette
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion, which represents...
IFF Announces Grant of Employment Inducement Awards
NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced the grant of employment inducement awards to J. Erik Fyrwald, IFF Chief Executive Officer and member of the Board of Directors. The Company's Board of Directors approved the employment inducement awards on Jan....
International Flavors (IFF) Q4 Earnings Lag Estimates, Dip Y/Y
International Flavors' (IFF) Q4 top line reflects softness in the Pharma and Nourish segments, offset by growth in the Scent, and Health & Biosciences segments.
International Flavors & Fragrances Cuts Dividend as Outlook Doesn't Pass the Smell Test
International Flavors expects 2024 revenue of between $10.8 billion and $11.1 billion, below analysts' consensus.
Compared to Estimates, International Flavors (IFF) Q4 Earnings: A Look at Key Metrics
The headline numbers for International Flavors (IFF) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
IFF Reports Fourth Quarter and Full Year 2023 Results
NEW YORK--(BUSINESS WIRE)---- $IFF--International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Consolidated Summary: Reported (GAAP) Adjusted (Non-GAAP)1 Sales Loss Before Taxes ...
International Flavors (IFF) to Post Q4 Earnings: What's in Store?
International Flavors' (IFF) Q4 results are likely to reflect the impacts of lower volumes and escalating costs.
Source: https://incomestatements.info
Category: Stock Reports